ISHARES TR - ISHARES BIOTECH - Call Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / ISHARES BIOTECH
Price per share
$168.77
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,500
Total reported value
$421,000
% of total 13F portfolios
0%
Share change
+2,500
Value change
+$421,000
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 1 institutional investors reported holding 2,500 shares of ISHARES TR - ISHARES BIOTECH - Call.

Institutional Holders of ISHARES TR - ISHARES BIOTECH - Call across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,500 $421,000 +$421,000 $168.77 1
2025 Q3 $144.37 0
2025 Q2 $126.51 0
2025 Q1 $127.90 0
2024 Q4 $132.21 0
2024 Q3 $145.60 0
2024 Q2 $137.26 0
2024 Q1 $137.22 0
2023 Q4 $135.85 0
2023 Q3 $118.25 0
2023 Q2 $108.99 0
2023 Q1 $114.61 0
2022 Q4 $123.86 0
2022 Q3 $111.61 0
2022 Q2 $115.78 0
2022 Q1 $130.29 0
2021 Q4 $152.62 0
2021 Q3 $161.67 0
2021 Q2 $163.66 0
2021 Q1 $7602.66 0
2020 Q4 $89.79 0
2020 Q3 $135.50 0
2020 Q2 0 $0 -$204,000 $136.69 0
2020 Q1 1,900 $204,000 +$204,000 $107.75 1
2019 Q4 0 $0 -$1,860,000 $120.51 0
2019 Q3 18,700 $1,860,000 +$1,860,000 $99.47 1
2019 Q2 $108.19 0
2019 Q1 0 $0 -$70,000,000 $58.74 0
2018 Q4 200 $70,000,000 +$69,340,000 $96.43 1
2018 Q3 5,500 $660,000 +$660,000 $120.97 1
2018 Q2 $55.37 0
2018 Q1 $106.75 0
2017 Q4 $2.93 0
2017 Q3 $330.54 0
2017 Q2 $310.00 0
2017 Q1 0 $0 -$2,760,000 $293.23 0
2016 Q4 10,400 $2,760,000 +$2,760,000 $265.36 1
2016 Q3 0 $0 -$36,000 $289.46 0
2016 Q2 1,200 $36,000 $30.00 1
2016 Q1 $260.80 0
2015 Q4 0 $0 -$32,000 $338.33 0
2015 Q3 70,000 $32,000 +$32,000 $303.33 1
2015 Q2 $368.97 0
2015 Q1 $331.57 0
2014 Q4 $303.35 0
2014 Q3 $273.63 0
2014 Q2 $255.98 0
2014 Q1 $233.49 0